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Background: Sudden cardiac death (SCD) primary prevention guidelines advocate implantable cardioverter and defibrillators (ICD) in patients 
with reduced left ventricular ejection fraction (LVEF). Real-life data suggest that the benefit from ICD therapy may be lower than expected from 
controlled studies and that the side effects are not negligible. It is also unclear if women benefit from treatment to the same extent as men. The aim 
of our study was to compare the results for men and women with primary preventive ICD, in an unselected population of patients with congestive 
heart failure.
methods: We studied 866 consecutive patients with reduced LVEF receiving ICD for primary prevention of SCD during 2006-2011 in four 
large Swedish hospitals (age 64±11 years, 82% men, 55% CRT-D). The patients’ records were scrutinized for presence of appropriate therapies, 
complications related to the defibrillator and all cause mortality. Mean follow-up was 35±14 months.
results: Many patients,18% (155 patients), received appropriate ICD therapy , either by anti-tachy pacing (ATP), shocks or both. Men were twice 
as likely to receive ICD treatment compared to women (20% vs. 9%), but neither total mortality (18% vs. 20%) or complication rates (13% in both 
groups) differed but there was a tendency that men had more inappropriate therapy (7,7% vs. 3,9%).
conclusion: Arrhythmias are common amongst primary preventive ICD recipients. Women are less likely to have lifesaving ICD treatment, but have 
the same extent of treatment complications, thus reducing their net benefit of the treatment.
